Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence of early ovarian aging in fragile X premutation carriers.

The Journal of clinical endocrinology and metabolism - 1 Sept 2004

Welt C K, Smith P C, Taylor A E

Abstract excerpt

Up to 28% of female fragile X premutation carriers develop premature ovarian failure. To test the hypothesis that fragile X premutation carriers with ovulatory menstrual cycles exhibit hormone changes characteristic of early ovarian aging, 11 regularly cycling fragile X premutation carriers, 24-41 yr old (34.5 +/- 5.7 yr, mean +/- sd), drew daily blood samples across one menstrual cycle. LH, FSH, estradiol,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estradiol
Share to Follicle Stimulating Hormone
Share to Fragile X Mental Retardation Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fragile X Syndrome

Share to Inhibins

Share to Menstrual Cycle

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 15356064
DOI: 10.1210/jc.2004-0347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence of early ovarian aging in fragile X premutation carriers.PMID 15356064Read ↗

Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.Semantic proximity Read ↗

Ovarian aging: mechanisms and intervention strategiesSemantic proximity Read ↗

Ovarian Aging: Molecular Mechanisms and Medical Management.Semantic proximity Read ↗

Current understanding of ovarian aging.Semantic proximity Read ↗

Ovarian Aging: Mechanisms and Clinical ConsequencesSemantic proximity Read ↗

Dynamics of the Ovarian Reserve and Impact of Genetic and Epidemiological Factors on Age of Menopause1Semantic proximity Read ↗

Genomic Markers of Ovarian ReserveSemantic proximity Read ↗

Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.Semantic proximity Read ↗

Prospectively assessing risk for premature ovarian senescence in young females: a new paradigmSemantic proximity Read ↗

Genetic insights into biological mechanisms governing human ovarian ageing.Semantic proximity Read ↗

Genetic insights into the biological mechanisms governing human ovarian ageingSemantic proximity Read ↗

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.